3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
2
Withdrawn
1
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Glioblastoma
39
Breast Neoplasms
23
Gliosarcoma
22
Esophageal Neoplasms
21
Prostatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
19
Pancreatic Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
13
Rectal Neoplasms
13
Brain Neoplasms
13
Uterine Cervical Neoplasms
12
Neoplasms
12
Glioma
12
Lung Neoplasms
11
Head and Neck Neoplasms
11
Melanoma
10
Astrocytoma
10
Sarcoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Central Nervous System Neoplasms
8
Stomach Neoplasms
7
Lymphoma, Follicular
6
Esophageal Squamous Cell Carcinoma
6
Endometrial Neoplasms
6
Adenocarcinoma Of Esophagus
6
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Lymphoma
5
Carcinoma
5
Rhabdomyosarcoma
4
Interventions
Cyclophosphamide
67
Dexamethasone
52
Peripheral Blood Stem Cell Transplantation
37
Lenalidomide
37
Rituximab
35
fludarabine phosphate
34
Bortezomib
30
Filgrastim
27
Etoposide
27
Cytarabine
25
Carboplatin
25
Busulfan
23
Radiotherapy
22
Melphalan
22
Gemcitabine
22
Cyclosporine
21
pomalidomide
20
fludarabine
20
Whole-Body Irradiation
20
Mycophenolic Acid
20
Paclitaxel
19
Methotrexate
18
venetoclax
17
Cisplatin
17
pembrolizumab
16
Calcium Dobesilate
16
Bevacizumab
16
Tacrolimus
14
Antilymphocyte Serum
14
Nivolumab
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Recurrence
×
Radiation
×
Clear all
NCT00975520
2024-11-27
RTN2
Melanoma and Skin Cancer Trials Limited
Phase NA
Completed
50 enrolled